ARX is now second biggest stock in my portfolio which I have accumulated over the past few months.
Not having a chatter is a good thing IMO. ARX has past beyond speculative biotech phase. It's about numbers on the board now. Half year reports would be time when some chatter would occur.
I prefer steady rise to $2.
Come on finish 1.60 plus, page-222
Add ARX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.0¢ |
Change
-0.010(1.85%) |
Mkt cap ! $182.4M | |||
| Open | High | Low | Value | Volume |
| 53.0¢ | 54.5¢ | 53.0¢ | $29.59K | 55.57K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 13850 | 53.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 54.0¢ | 13585 | 1 |
View Market Depth
| Last trade - 16.10pm 07/05/2024 (20 minute delay) ? |
|
|||||
|
Last
53.5¢ |
Change
-0.010 ( 1.87 %) |
||||
| Open | High | Low | Volume | ||
| 53.5¢ | 53.5¢ | 53.5¢ | 1281 | ||
| Last updated 10.40am 07/05/2024 ? | |||||
| ARX (ASX) Chart |